#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adenocarcinoma gastric Choroidal dystrophy Frontotemporal dementia Microscopic polyangiitis Urethral valves Uveal melanoma Prostate cancer Kaposi's sarcoma Idiopathic intracranial hypertension Paraganglion neoplasm Myeloproliferative neoplasm Acute lymphocytic leukaemia Hypergammaglobulinaemia benign monoclonal Neovascular age-related macular degeneration Raynaud's phenomenon More trials…

    Learn about Rare Diseases

    Primary mediastinal large B-cell lymphoma Angelman’s syndrome Optic glioma – Basic Information Chondrosarcoma metastatic – Basic Information Vascular malformation Indolent systemic mastocytosis – Basic Information Burkitt’s lymphoma – Basic Information Choroid melanoma – Diagnostics Rett syndrome – Treatment Turner’s syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ketoprofen Palopegteriparatide CHONDROITIN SULFATE SODIUM Mexiletine Hydrochloride Liraglutide Ertapenem Senicapoc Padeliporfin Vedolizumab Gen1053 TIFCEMALIMAB Silibinin Calcium Chloride Nofazinlimab Clodronate Disodium AGA2118 GVV858 Coffee Charcoal Digoxin Immune Fab (Ovine) Varegacestat More therapies…

    Learn about Your Condition

    Varices oesophageal Pseudomonas infection Injury Autoimmune disorder Rhabdomyosarcoma recurrent Intracranial aneurysm Lymphoedema Palmoplantar pustulosis Colon cancer Fontan procedure Obsessive-compulsive disorder Hyperphagia Hypersensitivity Basal cell naevus syndrome Thrombosis prophylaxis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Overweight

  • A study to evaluate the efficacy and safety of eloralintide in adults with obesity or overweight and type 2 diabetes

    Recruiting

    3 1
    Investigated Drugs:
    • LY3841136 SODIUM
    Czechia Germany Poland Slovakia Spain

  • Efficacy and safety of oral semaglutide for weight loss in adults with overweight or obesity

    Recruiting

    3 1 1
    Investigated Diseases:
    • Overweight
    • Obesity
    Investigated Drugs:
    • Semaglutide
    Belgium Bulgaria Denmark France Greece The Netherlands +3

  • Semaglutide and Granisetron for Tolerability in Overweight Adults Without Diabetes

    Recruiting

    3 1 1
    Investigated Diseases:
    • Overweight
    • Obesity
    Investigated Drugs:
    • Granisetron
    • Semaglutide
    Estonia

  • Zenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

    Recruiting

    3 1 1
    Investigated Diseases:
    • Overweight
    • Type 2 diabetes mellitus
    • Obesity
    Investigated Drugs:
    • Semaglutide
    Bulgaria Croatia Germany Hungary Poland Portugal +1

  • A Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes

    Recruiting

    3 1
    Investigated Diseases:
    • Overweight
    • Type 2 diabetes mellitus
    • Obesity
    Croatia Hungary Italy Romania Slovakia

  • A study of eloralintide in adults with persistent obesity or overweight who are currently treated with a weekly incretin medication

    Recruiting

    3 1
    Investigated Diseases:
    • Overweight
    • Obesity
    Investigated Drugs:
    • LY3841136 SODIUM
    Belgium Czechia Romania Spain
1 2 3 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!